Administration of PYY 3-36 also results in improved glucose control, improved lipid metabolism, and diminished insulin resistance in rodent models 1,38,41
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
You should never double your GLP-1 injection dose to compensate for a missed injection
Further reading FcRn blockade in CIDP (ADHERE trial) The Lancet Neurology 2024 #PatientEducation #CIDP #Neuromuscular #EvidenceBasedMedicine Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial thelancet.com To view or add a comment, sign in Platelet Hyperreactivity: A Novel Peripheral Biomarker for Preclinical Alzheimers
If the medication has been paused for an extended period, healthcare providers may recommend restarting at a lower dose before increasing again
Factors such as diet, exercise, and overall health will all play a part in how fast desired results from semaglutide GLP-1 treatment take